<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-id journal-id-type="iso-abbrev">Br. J. Cancer</journal-id><journal-title-group><journal-title>British Journal of Cancer</journal-title></journal-title-group><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22814581</article-id><article-id pub-id-type="pmc">3425966</article-id><article-id pub-id-type="pii">bjc2012332</article-id><article-id pub-id-type="doi">10.1038/bjc.2012.332</article-id><article-categories><subj-group subj-group-type="heading"><subject>Epidemiology</subject></subj-group></article-categories><title-group><article-title>Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit</article-title><alt-title alt-title-type="running">Gastric atrophy and oesophageal squamous cell carcinoma</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nasrollahzadeh</surname><given-names>D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Malekzadeh</surname><given-names>R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="caf1">*</xref></contrib><contrib contrib-type="author"><name><surname>Aghcheli</surname><given-names>K</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Sotoudeh</surname><given-names>M</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Merat</surname><given-names>S</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Islami</surname><given-names>F</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Kamangar</surname><given-names>F</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Abnet</surname><given-names>C C</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Shakeri</surname><given-names>R</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Pourshams</surname><given-names>A</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Semnani</surname><given-names>S</given-names></name><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Boffetta</surname><given-names>P</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Dawsey</surname><given-names>S M</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="caf2">*</xref></contrib><aff id="aff1"><label>1</label><institution>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet</institution>, Stockholm 17177, <country>Sweden</country></aff><aff id="aff2"><label>2</label><institution>Digestive Disease Research Center, Tehran University of Medical Sciences</institution>, North Karegar Ave., Tehran 14117, <country>Iran</country></aff><aff id="aff3"><label>3</label><institution>Institute for Translational Epidemiology and Tisch Cancer Institute, Mount Sinai School of Medicine</institution>, New York, NY 10029-6574, <country>USA</country></aff><aff id="aff4"><label>4</label><institution>Department of Public Health Analysis, School of Community Health and Policy, Morgan State University</institution>, Baltimore, MD 21251, <country>USA</country></aff><aff id="aff5"><label>5</label><institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute</institution>, Bethesda, MD 20892-7335, <country>USA</country></aff><aff id="aff6"><label>6</label><institution>Golestan Research Center of Gastroenterology and Hepatology, Gorgan University of Medical Sciences</institution>, Gorgan 49175-1141, <country>Iran</country></aff></contrib-group><author-notes><corresp id="caf1"><label>*</label>E-mail: <email>malek@ams.ac.ir</email></corresp><corresp id="caf2"><label>*</label>E-mail: <email>weimin.ye@ki.se</email></corresp></author-notes><pub-date pub-type="ppub"><day>21</day><month>08</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>19</day><month>07</month><year>2012</year></pub-date><volume>107</volume><issue>5</issue><fpage>888</fpage><lpage>894</lpage><history><date date-type="received"><day>12</day><month>04</month><year>2012</year></date><date date-type="rev-recd"><day>29</day><month>06</month><year>2012</year></date><date date-type="accepted"><day>05</day><month>07</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2012 Cancer Research UK</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>Cancer Research UK</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0/"><license-p>From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/</license-p></license></permissions><abstract><sec><title>Background:</title><p>Gastric fundal atrophy has been hypothesised to increase the risk of oesophageal squamous cell carcinoma (OSCC), but studies have shown inconsistent results.</p></sec><sec><title>Methods:</title><p>We measured serum pepsinogen I (PGI) and pepsinogen II (PGII) among 293 incident cases and 524 matched neighbourhood controls in a high-risk area of Northern Iran. Conditional logistic regression model was used to estimate odds ratios (ORs) and their 95&#x00025; confidence intervals (CIs).</p></sec><sec><title>Results:</title><p>After controlling for age, sex, residence area and other potential confounders, gastric atrophy (defined by a validated criterion, PGI &#x0003c;55&#x02009;<italic>&#x003bc;</italic>g&#x02009;dl<sup>&#x02212;1</sup>) was associated with a two-fold increased risk (OR=2.01, 95&#x00025; CI: 1.18, 3.45) of OSCC in the absence of nonatrophic pangastritis (defined as PGII &#x0003c;11.8&#x02009;<italic>&#x003bc;</italic>g&#x02009;dl<sup>&#x02212;1</sup>). Stratification by PGII decreased the misclassification errors due to cancer-induced gastritis. Presence of both poor dental health, indicated by higher than median sum of decayed, missing, and filled teeth (DMFT score), and gastric atrophy further increased the risk of OSCC (OR=4.15, 95&#x00025; CI: 2.04, 8.42) with relative excess risk due to interaction (RERI) of 1.47 (95&#x00025; CI: &#x02212;1.15, 4.1). Coexistence of poor oral hygiene habit with gastric atrophy elevated OSCC risk eight times (OR=8.65, 95&#x00025; CI: 3.65, 20.46) and the additive interaction index was marginally statistically significant (RERI=4.34, 95&#x00025; CI: &#x02212;1.07, 9.76).</p></sec><sec><title>Conclusion:</title><p>Gastric atrophy is a risk factor for OSCC, and poor dental health and oral hygiene habit may act synergistically in increasing the risk.</p></sec></abstract><kwd-group><kwd>atrophic gastritis</kwd><kwd>oesophageal neoplasm</kwd><kwd>relative risk</kwd><kwd>dental health</kwd><kwd>oral hygiene</kwd><kwd>pepsinogen</kwd></kwd-group></article-meta></front><body><p>Oesophageal cancer is the eighth most common cause of cancer death worldwide (<xref ref-type="bibr" rid="bib12">Jemal <italic>et al</italic>, 2011</xref>). Gastric atrophy as a consequence of chronic <italic>Helicobacter pylori</italic> infection was linked to an increased risk of oesophageal squamous cell carcinoma (OSCC) in a Swedish population-based case&#x02013;control study (<xref ref-type="bibr" rid="bib30">Ye <italic>et al</italic>, 2004</xref>). In the atrophic stomach, hypochlorohydria allows bacterial overgrowth (<xref ref-type="bibr" rid="bib29">Viani <italic>et al</italic>, 2000</xref>) and may produce potential carcinogenic substances, such as nitrosamines, which are also related to alcohol drinking and tobacco smoking (<xref ref-type="bibr" rid="bib19">Millonig <italic>et al</italic>, 2011</xref>). Histology is the gold standard for diagnosing gastric atrophy. However, because of its inconvenience in large epidemiological studies, serum level of pepsinogens has been applied as a replacement method. Pepsinogen I (PGI) is produced in the fundic glands and decreases proportionally with progression of fundic atrophy. Pepsinogen II (PGII) is synthesised in most parts of the gastric mucosa and part of the duodenum and some studies have shown its importance in detecting inflammation (<xref ref-type="bibr" rid="bib9">He <italic>et al</italic>, 2011</xref>) or gastric cancer screening (<xref ref-type="bibr" rid="bib3">Abnet <italic>et al</italic>, 2011</xref>). Magnitude of the reported associations between serological gastric atrophy and OSCC varied from null to eightfold (<xref ref-type="bibr" rid="bib10">Iijima <italic>et al</italic>, 2007</xref>; <xref ref-type="bibr" rid="bib8">de Vries <italic>et al</italic>, 2009</xref>; <xref ref-type="bibr" rid="bib26">Ren <italic>et al</italic>, 2009</xref>; <xref ref-type="bibr" rid="bib7">Cook <italic>et al</italic>, 2010</xref>; <xref ref-type="bibr" rid="bib28">Venerito <italic>et al</italic>, 2011</xref>).</p><p>Poor oral and dental hygiene are also linked to nitrosamine (<xref ref-type="bibr" rid="bib18">Meurman and Uittamo, 2008</xref>) and acetaldehyde production(<xref ref-type="bibr" rid="bib23">National Toxicology Program, 2010</xref>). In addition, poor oral hygiene and dental health have been shown to be associated with an increased risk of OSCC in high-risk areas (<xref ref-type="bibr" rid="bib2">Abnet <italic>et al</italic>, 2001</xref>, <xref ref-type="bibr" rid="bib1">2008</xref>). Previous studies have not tested possible synergism between these two risk factors. Golestan province in Iran is located in the Asian Oesophageal Cancer Belt and has some of the highest incidence rates for OSCC (<xref ref-type="bibr" rid="bib15">Mahboubi <italic>et al</italic>, 1973</xref>; <xref ref-type="bibr" rid="bib27">Saidi <italic>et al</italic>, 2000</xref>). Unlike low-risk areas, tobacco and alcohol use are not major risk factors for OSCC in this belt (<xref ref-type="bibr" rid="bib22">Nasrollahzadeh <italic>et al</italic>, 2008</xref>), from which 90&#x00025; of the OSCC cases arise worldwide. We evaluated the association between gastric atrophy (measured by serum pepsinogen level) and OSCC in a population-based case&#x02013;control study in Northern Iran and tested joint effect on OSCC risk in the presence of both gastric atrophy and poor oral hygiene.</p><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Case and control selection</title><p>Details of subject selection have been reported earlier (<xref ref-type="bibr" rid="bib22">Nasrollahzadeh <italic>et al</italic>, 2008</xref>). Briefly, case subjects were recruited at Atrak clinic, the only specialised clinic for oesophageal cancer diagnosis and treatment in eastern Golestan, from December 2003 to June 2007. Included cases were those of histopathologically confirmed OSCC patients who underwent oesophago-gastro-duodenal videoscopy at Atrak clinic and agreed to participate in the study. The reports of the local cancer registry demonstrated that &#x0223c;70&#x00025; of all incident cases during the study period were referred to Atrak clinic (unpublished data). Attempts were made to select two population-based control subjects, individually matched to the cases by age (&#x000b1;2 years), sex, and from the same neighbourhood or village using annually updated family health census. List of all potentially eligible controls for rural cases was ordered randomly in each village and for urban cases was ordered by geographic proximity to the case's residence. In all, 77&#x00025; of the enrolled controls were the first selected neighbours, and 11&#x00025; and 3&#x00025;, respectively, were the second and third choices from the lists. Absence of the eligible control at the time of invitation was almost always the reason for not participating in the study. In total, we recruited 300 cases and 571 matched controls.</p><p>To investigate whether OSCC cases have higher risk of developing non-atrophic gastritis in histology, we used another set of controls. Controls were consisted of endoscopy room patients who were referred to Atrak clinic with a suspicion of upper gastrointestinal malignancies during same period of case enrolment and were matched for age and sex. Three biopsy tissues from lesser-curvature antrum, lesser-curvature body and cardia were available for 261 cases (88&#x00025;) and 274 controls.</p></sec><sec><title>Interview and examination</title><p>After obtaining written informed consent from each subject, a nurse and a physician administered a structured questionnaire. A nutritionist administered a validated food frequency questionnaire (<xref ref-type="bibr" rid="bib16">Malekshah <italic>et al</italic>, 2006</xref>). All interviews were conducted face to face at Atrak clinic for case subjects and at health centres for controls except those chosen from Gonbad city who were interviewed at Golestan Cohort Centre. No proxies were used.</p><p>The trained physicians examined each patient's oral cavity and teeth. Number of decayed, missing, and filled teeth (DMFT score) in addition to frequency of tooth brushing was recorded. Detailed information has been published elsewhere (<xref ref-type="bibr" rid="bib1">Abnet <italic>et al</italic>, 2008</xref>). Reliability of measuring tooth count using &#x003ba; statistic was 0.86 (<xref ref-type="bibr" rid="bib25">Pourshams <italic>et al</italic>, 2005</xref>). Data was collected on demographic variables, ethnicity, alcohol consumption, lifelong history of tobacco or opium use, medication, and several potential confounders.</p></sec><sec><title>Serological data</title><p>Prior to endoscopy, an experienced nurse collected 12&#x02009;ml venous blood sample from each case subject. A trained technician immediately separated serum and stored it at &#x02212;80&#x02009;&#x000b0;C. Collected blood samples from matched controls were transferred on ice in a cooler box (&#x0223c;4&#x02009;&#x000b0;C). Time between collection and processing of neighbourhood control samples was &#x0003c;12&#x02009;h. For those controls who were interviewed at the Golestan Cohort Centre, sample processing and storage were performed immediately. Samples were transported on dry ice to Karolinska Institutet, Sweden, and stored at &#x02212;20&#x02009;&#x000b0;C prior to analysis. Serum pepsinogen I and II were measured blinded to case&#x02013;control status using enzyme-linked immunosorbent assays (Biohit, Helsinki, Finland). Aliquots from a pool of serum samples of healthy individuals were distributed among nine assay plates (two samples per plate). The coefficients of variation were 8&#x00025; and 14&#x00025; for PGI and PGII, respectively. <italic>H. pylori</italic> serology was evaluated qualitatively with western blot assay (Helico Blot 2.1; MP Biomedicals Asia Pacific Ltd, Singapore, Singapore). <italic>H. pylori</italic> infection was considered positive if (1) both 19.5- and 30-kDa bands were present or (2) any of the 35-, 37-, or 89-kDa band was present. CagA was positive if 116-kDa band was present. We have carried out a validation study in the same population with similar ethnic structure among 309 endoscopy clinic patients and compared pepsinogen serology with histology using modified Sydney classification as the gold standard. We reported PGI&#x0003c;55&#x02009;<italic>&#x003bc;</italic>g&#x02009;l<sup>&#x02212;1</sup> (sensitivity: 61.9&#x00025;, specificity: 94.8&#x00025;) as the optimal cutoff point for serological diagnosis of gastric fundal atrophy in the study population. At cutoff concentration of 11.8&#x02009;<italic>&#x003bc;</italic>g&#x02009;l<sup>&#x02212;1</sup>, PGII demonstrated 84.2&#x00025; sensitivity and 45.4&#x00025; specificity to distinguish nonatrophic pangastritis (<xref ref-type="bibr" rid="bib21">Nasrollahzadeh <italic>et al</italic>, 2011</xref>).</p></sec><sec><title>Statistical methods</title><p>Serum PGI and PGII were analysed as dichotomous variables using validated cutoff points. There was no <italic>a priori</italic> DMFT cutoff value, and cubic spline curve did not highlight any specific pattern, therefore the median DMFT was considered as a cutoff value for dichotomising it. Conditional logistic regression models were used to calculate odds ratios (ORs) and 95&#x00025; confidence intervals (CIs). In design, case and control subjects were individually matched for age, sex, and place of residence. ORs were further adjusted for education, ethnicity (Turkmen <italic>vs</italic> non-Turkmen), tobacco and opium use, alcohol drinking, and fruit/vegetable consumption. Interaction on additive scale between dichotomous variables of gastric atrophy and poor dental health or oral hygiene habit was evaluated and the relative excess risk due to interaction (RERI), attributable proportion and synergy index were calculated. Delta method was applied to calculate 95&#x00025; CI for measures of interaction. To address the effect of bias due to measurement error in serology assay, the ORs adjusted for misclassification as a function of different sensitivity and specificity for cases and controls were calculated using external validation data. Two-sided <italic>P</italic>-values &#x02a7d;0.05 were considered as statistically significant. All analyses were done using Stata version 11.1 (StataCorp., College Station, TX, USA).</p></sec><sec><title>Ethical approval</title><p>This study was approved by the ethical committee of the Digestive Disease Research Centre of Tehran University of Medical Sciences, Iran, the Institutional Review Board of National Cancer Institute, USA, and the Stockholm Regional Ethics Vetting Board, Sweden.</p></sec></sec><sec sec-type="results"><title>Results</title><p>The study included 300 incident case patients and 571 matched control subjects from whom serum samples were available for 293 (98&#x00025;) cases and 524 (92&#x00025;) controls. All cases had at least one matched control. Demographic characteristics of the study participants and potential confounders are summarised in <xref rid="tbl1" ref-type="table">Table 1</xref>. No substantial differences were observed between those who provided serum and those whose serum samples were not available.</p><p><xref rid="tbl2" ref-type="table">Table 2</xref> demonstrates proportion of subjects with serological gastric atrophy and ORs for association of PGI and PGII with OSCC risk after further controlling for education level and ethnicity (as socioeconomic index), opium and tobacco use, fruit, vegetable, and alcohol consumption. A PGI &#x0003c;55&#x02009;<italic>&#x003bc;</italic>g&#x02009;l<sup>&#x02212;1</sup> was associated with a 1.39-fold increased risk of OSCC (95&#x00025; CI: 0.93, 2.09). Histological diagnosis of non-atrophic gastritis was found in 30&#x00025; of OSCC cases with 2-fold risk comparing clinic controls (OR=1.97, 95&#x00025; CI: 1.13, 3.45) (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table</xref>). Because gastritis might be caused secondary to OSCC, we evaluated the association of gastric fundal atrophy with OSCC in combination with severe nonatrophic pangastritis. Combination of PGI &#x0003c;55&#x02009;<italic>&#x003bc;</italic>g&#x02009;l<sup>&#x02212;1</sup> and PGII &#x0003c;11.8&#x02009;<italic>&#x003bc;</italic>g&#x02009;l<sup>&#x02212;1</sup> was associated with a two-fold increased risk for OSCC. Further adjustment for tea-drinking habit as a suggested strong risk factor in this population (<xref ref-type="bibr" rid="bib11">Islami <italic>et al</italic>, 2009</xref>) did not alter the observed estimates. <italic>H. pylori</italic> serology, measured as antibodies against either whole <italic>H. pylori</italic> or CagA, was not associated with OSCC risk.</p><p>We applied other published thresholds for atrophy, including PGI &#x0003c;30&#x02009;<italic>&#x003bc;</italic>g&#x02009;l<sup>&#x02212;1</sup>, PGI/PGII ratio &#x0003c;3 and PGI &#x0003c;70&#x02009;<italic>&#x003bc;</italic>g&#x02009;l<sup>&#x02212;1</sup>, PGI/PGII ratio &#x0003c;3. The measures of association did not change materially. Combination with PGII also showed similar results (<xref rid="tbl3" ref-type="table">Table 3</xref>).</p><p><xref rid="tbl4" ref-type="table">Table 4</xref> presents the results of joint effect of gastric atrophy, poor dental health, and oral hygiene habit on OSCC risk after breaking the matching factors. Adjusted OR for association of DMFT with OSCC was 1.60 (95&#x00025; CI: 1.14, 2.24). Although based on modest numbers of cases, presence of poor dental hygiene, indicated as higher than median DMFT, and gastric atrophy rendered a more than four-fold excess risk of OSCC compared with the group with neither poor dental hygiene nor atrophy. The RERI between low DMFT and atrophy was 1.47 (95&#x00025; CI: &#x02212;1.15, 4.1), synergy index (95&#x00025; CI) 1.90 (0.6, 6.1), and the attributable proportion (95&#x00025; CI) 0.36 (&#x02212;0.14, 0.85). We used frequency of tooth brushing as another measure of dental and oral hygiene in combination with gastric atrophy, which resulted in an eight-fold increase in OSCC risk (OR: 8.65, 95&#x00025; CI: 3.65, 20.46) compared with non-atrophic group who occasionally or regularly brush their teeth. The RERI between habit of never brushing teeth and atrophy was 4.34 (95&#x00025; CI: &#x02212;1.07, 9.76), synergy index 2.24 (95&#x00025; CI: 0.97, 5.15), and attributable proportion 0.49 (95&#x00025; CI: 0.14, 0.83). Although based on fewer sets, conditional logistic regression model showed similar results (data not shown).</p><p>To quantify the magnitude of misclassification bias that occurs in presence of nonatrophic gastritis, we estimated the classification probabilities using external validation study (<xref ref-type="bibr" rid="bib21">Nasrollahzadeh <italic>et al</italic>, 2011</xref>). Effects of the range of PGII levels on diagnostic accuracy of atrophy and corrected ORs for the association with OSCC are presented in <xref rid="tbl5" ref-type="table">Table 5</xref>. Differential misclassification of gastric atrophy for cut points with low specificity (&#x0003c;80&#x00025;) was far from the null. When exposure detection was better among controls, the resulted OR was extensively biased.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>In this study, gastric atrophy, as indicated by low serum pepsinogen, was associated with an increased risk of OSCC.</p><p>Pepsinogens are markers of mixed conditions, including gastritis and atrophy (<xref ref-type="bibr" rid="bib9">He <italic>et al</italic>, 2011</xref>), which could be of distinct etiologies in cancer patients. In spite of observed association between serological nonatrophic pangastritis with OSCC in our study, the probability of developing gastritis secondary to oesophageal cancer is not ignorable because of several evidences. Most importantly, studies with cohort design did not detect significant association between PGII and OSCC risk. In addition, cancer patients may develop gastritis due to non-steroidal anti-inflammatory drug (NSAID) use, opportunistic infections in stomach (cytomegalovirus, Epstein&#x02013;Barr virus), malnutrition, anaemia, and consequent use of iron tablets (<xref ref-type="bibr" rid="bib4">Abraham <italic>et al</italic>, 1999</xref>; <xref ref-type="bibr" rid="bib14">Lauwers <italic>et al</italic>, 2010</xref>). Stage of tumours in most of our study population were III or IV at the time of diagnosis, and dysphagia was the presenting symptom, which led to high proportion of NSAID consumption among cases compared with controls (24.7&#x00025; <italic>vs</italic> 15.8&#x00025;, <italic>P</italic>=0.001). On the other hand, development of marked atrophy needs long time period (<xref ref-type="bibr" rid="bib5">Adamu <italic>et al</italic>, 2011</xref>) and its initiation during OSCC progression with short lead time is unlikely. Thus, in studying the relationship between gastric atrophy and OSCC when serum collection period is close to cancer diagnosis, PGI provides more valid estimate than PGI/PGII ratio.</p><p>Low sensitivity for atrophy detection might lead to loss of precision and power by unnecessarily reducing the exposed sample size. We chose atrophy cutoff point at high specificity level (97&#x00025;) however, false negative probability of 0.4 and low prevalence of gastric atrophy could potentially result in misclassification of exposure among cases and controls. Which we believe, if evolves, would be differential.</p><p>Histology is the gold standard for atrophy diagnosis, however, detection of atrophy is difficult because of the limitation in number of biopsies and patchy nature of atrophy. Furthermore, mucosal inflammation and separation of glands by inflammatory infiltrate would add more diagnostic difficulties in severe gastritis (<xref ref-type="bibr" rid="bib24">Owen, 2003</xref>). Because inflammation among our cancer patients was more probable than healthy controls, the error probabilities for unexposed cases and controls might not be identical. To decrease the effect of mixed category and to reduce the problem of non-identical false-negative probabilities, we stratified the presence of nonatrophic pangastritis and observed a two-fold increased OSCC risk associated with atrophy.</p><p>Notably, reducing interpretations to a dichotomy could degrade the information. False-negative results are inherent in serological diagnosis of atrophy due to the low sensitivity of the diagnostic method. It is believed that resulted misclassification will drive the association toward null if non-differential assumptions are met. However, atrophy is an uncommon exposure and its binary value is the result of categorising continuous PGI variable. Therefore, we performed a sensitivity analysis with the external validation data. Our results confirmed that the effect of misclassification due to ignoring nonatrophic pangastritis on association between atrophy and OSCC was substantial. This finding suggests that PGII as a marker of severe inflammation could be used as a stratifying factor.</p><p>In this study, we could not detect any association between infection with <italic>cagA</italic>-positive <italic>H. pylori</italic> strains and OSCC risk, which is in contrast to the results from the study among low-risk Swedish population (<xref ref-type="bibr" rid="bib30">Ye <italic>et al</italic>, 2004</xref>), Japanese alcoholic males (<xref ref-type="bibr" rid="bib31">Yokoyama <italic>et al</italic>, 2009</xref>), and in accordance to the reports from studies in Linxian of China (<xref ref-type="bibr" rid="bib13">Kamangar <italic>et al</italic>, 2007</xref>), Magdeburg of Germany (<xref ref-type="bibr" rid="bib28">Venerito <italic>et al</italic>, 2011</xref>), and among Finnish male smokers (<xref ref-type="bibr" rid="bib7">Cook <italic>et al</italic>, 2010</xref>). Spontaneous disappearance of <italic>H. pylori</italic> over time or <italic>H. pylori</italic> eradication is possibly common in endemic areas. Acquired immunodeficiency among advanced malnourished cancer patients could be another explanation for reduced immune response to antigens. These possibilities could lead to heterogeneity of <italic>H. pylori</italic>-negative category as a reference. Hence, our risk estimates for <italic>H. pylori</italic> and CagA infection are inconclusive because of difficulties in achieving a clean reference group in an endemic area for <italic>H. pylori</italic> infection and among aged population in a case&#x02013;control design.</p><p>Our study might indicate areas to search for the underlying mechanism. There was a suggestive evidence that the estimated joint effect of poor dental health or never tooth brushing and gastric atrophy together was larger than the sum of their effects alone, which is in favour of the hypothesis of the bacterial overgrowth in atrophic stomach and low-hygiene periodontal mucosa (<xref ref-type="bibr" rid="bib17">Meurman and Bascones-Martinez, 2011</xref>). Endogenous formation of nitrosamines in the oral cavity of those with poor oral hygiene is eightfold higher than that in those with good oral hygiene (<xref ref-type="bibr" rid="bib20">Nair <italic>et al</italic>, 1996</xref>). Upstream microbial community members from the oral mucosa and oesophagus have the potential to translocate to the stomach, and they might act as reservoirs for recolonisation. Gastric microbiota shows considerable overlap with oral microbiota (<xref ref-type="bibr" rid="bib6">Bik <italic>et al</italic>, 2006</xref>), however, the mechanism of these two bacterial environment in OSCC carcinogenesis could be different. Our statistical inference on the presence of interaction between poor oral hygiene and gastric atrophy has less precision than the main finding of the study because of the modest sample size. The observed interaction might be due to other mechanisms, as tooth loss may be an indicator of a less healthy life style. However, we did not detect association between education as a socioeconomic status indicator and DMFT in our data. Also, low DMFT could be a marker for distinct diet because of reduced masticatory ability, hence, the detected association might be due to residual confounding.</p><p>This study was a population-based study, matching improved statistical efficiency, and sample size was the largest among the studies so far published. Markers of the main exposure and confounders were validated and extensive information on cofounders was available.</p><p>In conclusion, our population-based case&#x02013;control study confirms that gastric atrophy is a risk factor for OSCC in high-risk area of northern Iran. Excluding nonatrophic pangastritis through stratifying by PGII level decreases the possibility of PGI misclassification due to cancer-induced inflammation. Gastric atrophy and poor oral hygiene may act synergistically in increasing the risk of OSCC.</p></sec></body><back><ack><p>We thank the local health network workers (Behvarz) for their contribution to this study. This work was supported by Digestive Disease Research Centre of Tehran University of Medical Sciences (Grant 82-603), Swedish Research Council (VR- 60535801), intramural funds of the National Cancer Institute at the National Institutes of Health, Martin Rinds Foundation (Sweden), and KID grant, Karolinska Institutet faculty funds for postgraduate students (December 2008).</p></ack><fn-group><fn><p><xref ref-type="supplementary-material" rid="sup1">Supplementary Information</xref> accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc)</p></fn><fn><p>This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.</p></fn></fn-group><notes><p>The authors declare no conflict of interest.</p></notes><ref-list><ref id="bib1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Kamangar</surname><given-names>F</given-names></name><name><surname>Islami</surname><given-names>F</given-names></name><name><surname>Nasrollahzadeh</surname><given-names>D</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Aghcheli</surname><given-names>K</given-names></name><name><surname>Merat</surname><given-names>S</given-names></name><name><surname>Pourshams</surname><given-names>A</given-names></name><name><surname>Marjani</surname><given-names>HA</given-names></name><name><surname>Ebadati</surname><given-names>A</given-names></name><name><surname>Sotoudeh</surname><given-names>M</given-names></name><name><surname>Boffetta</surname><given-names>P</given-names></name><name><surname>Malekzadeh</surname><given-names>R</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name></person-group><year>2008</year><article-title>Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma</article-title><source>Cancer Epidemiol Biomarkers Prev</source><volume>17</volume><supplement>(11</supplement><fpage>3062</fpage><lpage>3068</lpage><pub-id pub-id-type="pmid">18990747</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Qiao</surname><given-names>YL</given-names></name><name><surname>Mark</surname><given-names>SD</given-names></name><name><surname>Dong</surname><given-names>ZW</given-names></name><name><surname>Taylor</surname><given-names>PR</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name></person-group><year>2001</year><article-title>Prospective study of tooth loss and incident esophageal and gastric cancers in China</article-title><source>Cancer Causes Control</source><volume>12</volume><supplement>(9</supplement><fpage>847</fpage><lpage>854</lpage><pub-id pub-id-type="pmid">11714113</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>Ye</surname><given-names>W</given-names></name><name><surname>Kamangar</surname><given-names>F</given-names></name><name><surname>Ji</surname><given-names>BT</given-names></name><name><surname>Persson</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>HL</given-names></name><name><surname>Rothman</surname><given-names>N</given-names></name><name><surname>Shu</surname><given-names>XO</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Chow</surname><given-names>WH</given-names></name></person-group><year>2011</year><article-title>Plasma pepsinogens, antibodies against <italic>Helicobacter pylori</italic>, and risk of gastric cancer in the Shanghai Women's Health Study Cohort</article-title><source>Br J Cancer</source><volume>104</volume><supplement>(9</supplement><fpage>1511</fpage><lpage>1516</lpage><pub-id pub-id-type="pmid">21407214</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>SC</given-names></name><name><surname>Yardley</surname><given-names>JH</given-names></name><name><surname>Wu</surname><given-names>TT</given-names></name></person-group><year>1999</year><article-title>Erosive injury to the upper gastrointestinal tract in patients receiving iron medication: an underrecognized entity</article-title><source>Am J Surg Pathol</source><volume>23</volume><supplement>(10</supplement><fpage>1241</fpage><lpage>1247</lpage><pub-id pub-id-type="pmid">10524525</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamu</surname><given-names>MA</given-names></name><name><surname>Weck</surname><given-names>MN</given-names></name><name><surname>Rothenbacher</surname><given-names>D</given-names></name><name><surname>Brenner</surname><given-names>H</given-names></name></person-group><year>2011</year><article-title>Incidence and risk factors for the development of chronic atrophic gastritis: five year follow-up of a population-based cohort study</article-title><source>Int J Cancer</source><volume>128</volume><supplement>(7</supplement><fpage>1652</fpage><lpage>1658</lpage><pub-id pub-id-type="pmid">20503273</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bik</surname><given-names>EM</given-names></name><name><surname>Eckburg</surname><given-names>PB</given-names></name><name><surname>Gill</surname><given-names>SR</given-names></name><name><surname>Nelson</surname><given-names>KE</given-names></name><name><surname>Purdom</surname><given-names>EA</given-names></name><name><surname>Francois</surname><given-names>F</given-names></name><name><surname>Perez-Perez</surname><given-names>G</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name><name><surname>Relman</surname><given-names>DA</given-names></name></person-group><year>2006</year><article-title>Molecular analysis of the bacterial microbiota in the human stomach</article-title><source>Proc Natl Acad Sci USA</source><volume>103</volume><supplement>(3</supplement><fpage>732</fpage><lpage>737</lpage><pub-id pub-id-type="pmid">16407106</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>MB</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name><name><surname>Diaw</surname><given-names>L</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name><name><surname>Perez-Perez</surname><given-names>GI</given-names></name><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Taylor</surname><given-names>PR</given-names></name><name><surname>Albanes</surname><given-names>D</given-names></name><name><surname>Virtamo</surname><given-names>J</given-names></name><name><surname>Kamangar</surname><given-names>F</given-names></name></person-group><year>2010</year><article-title>Serum pepsinogens and <italic>Helicobacter pylori</italic> in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study</article-title><source>Cancer Epidemiol Biomarkers Prev</source><volume>19</volume><supplement>(8</supplement><fpage>1966</fpage><lpage>1975</lpage><pub-id pub-id-type="pmid">20647397</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Vries</surname><given-names>AC</given-names></name><name><surname>Capelle</surname><given-names>LG</given-names></name><name><surname>Looman</surname><given-names>CW</given-names></name><name><surname>van Blankenstein</surname><given-names>M</given-names></name><name><surname>van Grieken</surname><given-names>NC</given-names></name><name><surname>Casparie</surname><given-names>MK</given-names></name><name><surname>Meijer</surname><given-names>GA</given-names></name><name><surname>Kuipers</surname><given-names>EJ</given-names></name></person-group><year>2009</year><article-title>Increased risk of esophageal squamous cell carcinoma in patients with gastric atrophy: independent of the severity of atrophic changes</article-title><source>Int J Cancer</source><volume>124</volume><supplement>(9</supplement><fpage>2135</fpage><lpage>2138</lpage><pub-id pub-id-type="pmid">19107937</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>CY</given-names></name><name><surname>Sun</surname><given-names>LP</given-names></name><name><surname>Gong</surname><given-names>YH</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Dong</surname><given-names>NN</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name></person-group><year>2011</year><article-title>Serum pepsinogen II: a neglected but useful biomarker to differentiate between diseased and normal stomachs</article-title><source>J Gastroenterol Hepatol</source><volume>26</volume><supplement>(6</supplement><fpage>1039</fpage><lpage>1046</lpage><pub-id pub-id-type="pmid">21303408</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iijima</surname><given-names>K</given-names></name><name><surname>Koike</surname><given-names>T</given-names></name><name><surname>Abe</surname><given-names>Y</given-names></name><name><surname>Inomata</surname><given-names>Y</given-names></name><name><surname>Sekine</surname><given-names>H</given-names></name><name><surname>Imatani</surname><given-names>A</given-names></name><name><surname>Nakaya</surname><given-names>N</given-names></name><name><surname>Ohara</surname><given-names>S</given-names></name><name><surname>Shimosegawa</surname><given-names>T</given-names></name></person-group><year>2007</year><article-title>Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous cell carcinoma in Japan</article-title><source>Am J Gastroenterol</source><volume>102</volume><supplement>(8</supplement><fpage>1603</fpage><lpage>1609</lpage><pub-id pub-id-type="pmid">17488251</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islami</surname><given-names>F</given-names></name><name><surname>Pourshams</surname><given-names>A</given-names></name><name><surname>Nasrollahzadeh</surname><given-names>D</given-names></name><name><surname>Kamangar</surname><given-names>F</given-names></name><name><surname>Fahimi</surname><given-names>S</given-names></name><name><surname>Shakeri</surname><given-names>R</given-names></name><name><surname>Abedi-Ardekani</surname><given-names>B</given-names></name><name><surname>Merat</surname><given-names>S</given-names></name><name><surname>Vahedi</surname><given-names>H</given-names></name><name><surname>Semnani</surname><given-names>S</given-names></name><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Moller</surname><given-names>H</given-names></name><name><surname>Saidi</surname><given-names>F</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name><name><surname>Malekzadeh</surname><given-names>R</given-names></name><name><surname>Boffetta</surname><given-names>P</given-names></name></person-group><year>2009</year><article-title>Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study</article-title><source>BMJ</source><volume>338</volume><fpage>b929</fpage><pub-id pub-id-type="pmid">19325180</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jemal</surname><given-names>A</given-names></name><name><surname>Bray</surname><given-names>F</given-names></name><name><surname>Center</surname><given-names>MM</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Ward</surname><given-names>E</given-names></name><name><surname>Forman</surname><given-names>D</given-names></name></person-group><year>2011</year><article-title>Global cancer statistics</article-title><source>CA Cancer J Clin</source><volume>61</volume><supplement>(2</supplement><fpage>69</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">21296855</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamangar</surname><given-names>F</given-names></name><name><surname>Qiao</surname><given-names>YL</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name><name><surname>Sun</surname><given-names>XD</given-names></name><name><surname>Katki</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>JH</given-names></name><name><surname>Perez-Perez</surname><given-names>GI</given-names></name><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Mark</surname><given-names>SD</given-names></name><name><surname>Taylor</surname><given-names>PR</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name></person-group><year>2007</year><article-title><italic>Helicobacter pylori</italic> and oesophageal and gastric cancers in a prospective study in China</article-title><source>Br J Cancer</source><volume>96</volume><supplement>(1</supplement><fpage>172</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">17179990</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauwers</surname><given-names>GY</given-names></name><name><surname>Fujita</surname><given-names>H</given-names></name><name><surname>Nagata</surname><given-names>K</given-names></name><name><surname>Shimizu</surname><given-names>M</given-names></name></person-group><year>2010</year><article-title>Pathology of non-<italic>Helicobacter pylori</italic> gastritis: extending the histopathologic horizons</article-title><source>J Gastroenterol</source><volume>45</volume><supplement>(2</supplement><fpage>131</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">19967418</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahboubi</surname><given-names>E</given-names></name><name><surname>Kmet</surname><given-names>J</given-names></name><name><surname>Cook</surname><given-names>PJ</given-names></name><name><surname>Day</surname><given-names>NE</given-names></name><name><surname>Ghadirian</surname><given-names>P</given-names></name><name><surname>Salmasizadeh</surname><given-names>S</given-names></name></person-group><year>1973</year><article-title>Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry</article-title><source>Br J Cancer</source><volume>28</volume><supplement>(3</supplement><fpage>197</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">4743904</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malekshah</surname><given-names>AF</given-names></name><name><surname>Kimiagar</surname><given-names>M</given-names></name><name><surname>Saadatian-Elahi</surname><given-names>M</given-names></name><name><surname>Pourshams</surname><given-names>A</given-names></name><name><surname>Nouraie</surname><given-names>M</given-names></name><name><surname>Goglani</surname><given-names>G</given-names></name><name><surname>Hoshiarrad</surname><given-names>A</given-names></name><name><surname>Sadatsafavi</surname><given-names>M</given-names></name><name><surname>Golestan</surname><given-names>B</given-names></name><name><surname>Yoonesi</surname><given-names>A</given-names></name><name><surname>Rakhshani</surname><given-names>N</given-names></name><name><surname>Fahimi</surname><given-names>S</given-names></name><name><surname>Nasrollahzadeh</surname><given-names>D</given-names></name><name><surname>Salahi</surname><given-names>R</given-names></name><name><surname>Ghafarpour</surname><given-names>A</given-names></name><name><surname>Semnani</surname><given-names>S</given-names></name><name><surname>Steghens</surname><given-names>JP</given-names></name><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Kamangar</surname><given-names>F</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Boffetta</surname><given-names>P</given-names></name><name><surname>Malekzadeh</surname><given-names>R</given-names></name></person-group><year>2006</year><article-title>Validity and reliability of a new food frequency questionnaire compared to 24&#x02009;h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer</article-title><source>Eur J Clin Nutr</source><volume>60</volume><supplement>(8</supplement><fpage>971</fpage><lpage>977</lpage><pub-id pub-id-type="pmid">16465196</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meurman</surname><given-names>JH</given-names></name><name><surname>Bascones-Martinez</surname><given-names>A</given-names></name></person-group><year>2011</year><article-title>Are oral and dental diseases linked to cancer</article-title><source>Oral Dis</source><volume>17</volume><supplement>(8</supplement><fpage>779</fpage><lpage>784</lpage><pub-id pub-id-type="pmid">21819493</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meurman</surname><given-names>JH</given-names></name><name><surname>Uittamo</surname><given-names>J</given-names></name></person-group><year>2008</year><article-title>Oral micro-organisms in the etiology of cancer</article-title><source>Acta Odontol Scand</source><volume>66</volume><supplement>(6</supplement><fpage>321</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">18821087</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millonig</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Homann</surname><given-names>N</given-names></name><name><surname>Bernhardt</surname><given-names>F</given-names></name><name><surname>Qin</surname><given-names>H</given-names></name><name><surname>Mueller</surname><given-names>S</given-names></name><name><surname>Bartsch</surname><given-names>H</given-names></name><name><surname>Seitz</surname><given-names>HK</given-names></name></person-group><year>2011</year><article-title>Ethanol-mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA-lesions</article-title><source>Int J Cancer</source><volume>128</volume><supplement>(3</supplement><fpage>533</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">20715111</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>J</given-names></name><name><surname>Ohshima</surname><given-names>H</given-names></name><name><surname>Nair</surname><given-names>UJ</given-names></name><name><surname>Bartsch</surname><given-names>H</given-names></name></person-group><year>1996</year><article-title>Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users</article-title><source>Crit Rev Toxicol</source><volume>26</volume><supplement>(2</supplement><fpage>149</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">8688158</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasrollahzadeh</surname><given-names>D</given-names></name><name><surname>Aghcheli</surname><given-names>K</given-names></name><name><surname>Sotoudeh</surname><given-names>M</given-names></name><name><surname>Shakeri</surname><given-names>R</given-names></name><name><surname>Persson</surname><given-names>EC</given-names></name><name><surname>Islami</surname><given-names>F</given-names></name><name><surname>Kamangar</surname><given-names>F</given-names></name><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Boffetta</surname><given-names>P</given-names></name><name><surname>Engstrand</surname><given-names>L</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name><name><surname>Malekzadeh</surname><given-names>R</given-names></name><name><surname>Ye</surname><given-names>W</given-names></name></person-group><year>2011</year><article-title>Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis</article-title><source>Plos One</source><volume>6</volume><supplement>(10</supplement><fpage>e26957</fpage><pub-id pub-id-type="pmid">22066020</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasrollahzadeh</surname><given-names>D</given-names></name><name><surname>Kamangar</surname><given-names>F</given-names></name><name><surname>Aghcheli</surname><given-names>K</given-names></name><name><surname>Sotoudeh</surname><given-names>M</given-names></name><name><surname>Islami</surname><given-names>F</given-names></name><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Shakeri</surname><given-names>R</given-names></name><name><surname>Pourshams</surname><given-names>A</given-names></name><name><surname>Marjani</surname><given-names>HA</given-names></name><name><surname>Nouraie</surname><given-names>M</given-names></name><name><surname>Khatibian</surname><given-names>M</given-names></name><name><surname>Semnani</surname><given-names>S</given-names></name><name><surname>Ye</surname><given-names>W</given-names></name><name><surname>Boffetta</surname><given-names>P</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name><name><surname>Malekzadeh</surname><given-names>R</given-names></name></person-group><year>2008</year><article-title>Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran</article-title><source>Br J Cancer</source><volume>98</volume><supplement>(11</supplement><fpage>1857</fpage><lpage>1863</lpage><pub-id pub-id-type="pmid">18475303</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>National Toxicology Program</collab></person-group><year>2010</year><article-title>Final report on carcinogens background document for formaldehyde</article-title><source>Rep Carcinog Backgr Doc</source><volume>(10-5981)</volume>i-512</mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owen</surname><given-names>DA</given-names></name></person-group><year>2003</year><article-title>Gastritis and carditis</article-title><source>Mod Pathol</source><volume>16</volume><supplement>(4</supplement><fpage>325</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">12692198</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pourshams</surname><given-names>A</given-names></name><name><surname>Saadatian-Elahi</surname><given-names>M</given-names></name><name><surname>Nouraie</surname><given-names>M</given-names></name><name><surname>Malekshah</surname><given-names>AF</given-names></name><name><surname>Rakhshani</surname><given-names>N</given-names></name><name><surname>Salahi</surname><given-names>R</given-names></name><name><surname>Yoonessi</surname><given-names>A</given-names></name><name><surname>Semnani</surname><given-names>S</given-names></name><name><surname>Islami</surname><given-names>F</given-names></name><name><surname>Sotoudeh</surname><given-names>M</given-names></name><name><surname>Fahimi</surname><given-names>S</given-names></name><name><surname>Sadjadi</surname><given-names>AR</given-names></name><name><surname>Nasrollahzadeh</surname><given-names>D</given-names></name><name><surname>Aghcheli</surname><given-names>K</given-names></name><name><surname>Kamangar</surname><given-names>F</given-names></name><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Saidi</surname><given-names>F</given-names></name><name><surname>Sewram</surname><given-names>V</given-names></name><name><surname>Strickland</surname><given-names>PT</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Boffetta</surname><given-names>P</given-names></name><name><surname>Malekzadeh</surname><given-names>R</given-names></name></person-group><year>2005</year><article-title>Golestan cohort study of oesophageal cancer: feasibility and first results</article-title><source>Br J Cancer</source><volume>92</volume><supplement>(1</supplement><fpage>176</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">15597107</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>JS</given-names></name><name><surname>Kamangar</surname><given-names>F</given-names></name><name><surname>Qiao</surname><given-names>YL</given-names></name><name><surname>Taylor</surname><given-names>PR</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Fan</surname><given-names>JH</given-names></name><name><surname>Abnet</surname><given-names>CC</given-names></name></person-group><year>2009</year><article-title>Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort</article-title><source>Gut</source><volume>58</volume><supplement>(5</supplement><fpage>636</fpage><lpage>642</lpage><pub-id pub-id-type="pmid">19136509</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saidi</surname><given-names>F</given-names></name><name><surname>Sepehr</surname><given-names>A</given-names></name><name><surname>Fahimi</surname><given-names>S</given-names></name><name><surname>Farahvash</surname><given-names>MJ</given-names></name><name><surname>Salehian</surname><given-names>P</given-names></name><name><surname>Esmailzadeh</surname><given-names>A</given-names></name><name><surname>Keshoofy</surname><given-names>M</given-names></name><name><surname>Pirmoazen</surname><given-names>N</given-names></name><name><surname>Yazdanbod</surname><given-names>M</given-names></name><name><surname>Roshan</surname><given-names>MK</given-names></name></person-group><year>2000</year><article-title>Oesophageal cancer among the Turkomans of northeast Iran</article-title><source>Br J Cancer</source><volume>83</volume><supplement>(9</supplement><fpage>1249</fpage><lpage>1254</lpage><pub-id pub-id-type="pmid">11027442</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venerito</surname><given-names>M</given-names></name><name><surname>Kohrs</surname><given-names>S</given-names></name><name><surname>Wex</surname><given-names>T</given-names></name><name><surname>Adolf</surname><given-names>D</given-names></name><name><surname>Kuester</surname><given-names>D</given-names></name><name><surname>Schubert</surname><given-names>D</given-names></name><name><surname>Peitz</surname><given-names>U</given-names></name><name><surname>Monkemuller</surname><given-names>K</given-names></name><name><surname>Malfertheiner</surname><given-names>P</given-names></name></person-group><year>2011</year><article-title><italic>Helicobacter pylori</italic> infection and fundic gastric atrophy are not associated with esophageal squamous cell carcinoma: a case-control study</article-title><source>Eur J Gastroenterol Hepatol</source><volume>23</volume><supplement>(10</supplement><fpage>859</fpage><lpage>864</lpage><pub-id pub-id-type="pmid">21811162</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viani</surname><given-names>F</given-names></name><name><surname>Siegrist</surname><given-names>HH</given-names></name><name><surname>Pignatelli</surname><given-names>B</given-names></name><name><surname>Cederberg</surname><given-names>C</given-names></name><name><surname>Idstrom</surname><given-names>JP</given-names></name><name><surname>Verdu</surname><given-names>EF</given-names></name><name><surname>Fried</surname><given-names>M</given-names></name><name><surname>Blum</surname><given-names>AL</given-names></name><name><surname>Armstrong</surname><given-names>D</given-names></name></person-group><year>2000</year><article-title>The effect of intra-gastric acidity and flora on the concentration of N-nitroso compounds in the stomach</article-title><source>Eur J Gastroenterol Hepatol</source><volume>12</volume><supplement>(2</supplement><fpage>165</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">10741930</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>W</given-names></name><name><surname>Held</surname><given-names>M</given-names></name><name><surname>Lagergren</surname><given-names>J</given-names></name><name><surname>Engstrand</surname><given-names>L</given-names></name><name><surname>Blot</surname><given-names>WJ</given-names></name><name><surname>McLaughlin</surname><given-names>JK</given-names></name><name><surname>Nyren</surname><given-names>O</given-names></name></person-group><year>2004</year><article-title><italic>Helicobacter pylori</italic> infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia</article-title><source>J Natl Cancer Inst</source><volume>96</volume><supplement>(5</supplement><fpage>388</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">14996860</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>A</given-names></name><name><surname>Omori</surname><given-names>T</given-names></name><name><surname>Yokoyama</surname><given-names>T</given-names></name><name><surname>Kawakubo</surname><given-names>H</given-names></name><name><surname>Mori</surname><given-names>S</given-names></name><name><surname>Matsui</surname><given-names>T</given-names></name><name><surname>Maruyama</surname><given-names>K</given-names></name></person-group><year>2009</year><article-title>Chronic atrophic gastritis and metachronous gastric cancer in Japanese alcoholic men with oesophageal squamous cell carcinoma</article-title><source>Alcohol Clin Exp Res</source><volume>33</volume><supplement>(5</supplement><fpage>898</fpage><lpage>905</lpage><pub-id pub-id-type="pmid">19320631</pub-id></mixed-citation></ref></ref-list><sec sec-type="supplementary-material" id="sup1"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="xob1"><label>Supplementary Table</label><media xmlns:xlink="http://www.w3.org/1999/xlink" mimetype="application" mime-subtype="msword" xlink:href="bjc2012332x1.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></back><floats-group><table-wrap id="tbl1"><label>Table 1</label><caption><title>Characteristics of OSCC cases and matched controls, Golestan province, Iran, 2003&#x02013;2007</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="char" char="("/><col align="char" char="("/><col align="char" char="."/><col align="char" char="("/><col align="char" char="."/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50"><bold>Characteristics</bold></th><th align="center" valign="top" char="(" charoff="50"><bold>Cases (</bold><italic><bold>n</bold></italic><bold>=293)</bold></th><th align="center" valign="top" char="(" charoff="50"><bold>Controls (</bold><italic><bold>n</bold></italic><bold>=524)</bold></th><th align="center" valign="top" char="." charoff="50"><italic><bold>P</bold></italic><bold>-value</bold></th><th align="center" valign="top" char="(" charoff="50"><bold>Controls without serum samples (</bold><italic><bold>n</bold></italic><bold>=47)</bold></th><th align="center" valign="top" char="." charoff="50"><italic><bold>P</bold></italic><bold>-value</bold><xref ref-type="fn" rid="t1-fn2">a</xref></th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">Mean age (s.d.), years</td><td align="char" valign="top" char="(" charoff="50">64.4 (11.1)</td><td align="char" valign="top" char="(" charoff="50">65.5 (10.4)</td><td align="char" valign="top" char="." charoff="50">0.95</td><td align="char" valign="top" char="(" charoff="50">62.1 (9.9)</td><td align="char" valign="top" char="." charoff="50">0.07</td></tr><tr><td colspan="6" align="left" valign="top" charoff="50"><italic>Sex (&#x00025;)</italic></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Men</td><td align="char" valign="top" char="(" charoff="50">147 (50.2)</td><td align="char" valign="top" char="(" charoff="50">256 (48.8)</td><td align="char" valign="top" char="." charoff="50">0.71</td><td align="char" valign="top" char="(" charoff="50">22 (46.8)</td><td align="char" valign="top" char="." charoff="50">0.8</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Women</td><td align="char" valign="top" char="(" charoff="50">146 (49.8)</td><td align="char" valign="top" char="(" charoff="50">268 (51.2)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">25 (53.2)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td colspan="6" align="left" valign="top" charoff="50"><italic>Residence area (&#x00025;)</italic></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Urban</td><td align="char" valign="top" char="(" charoff="50">80 (27.3)</td><td align="char" valign="top" char="(" charoff="50">133 (25.4)</td><td align="char" valign="top" char="." charoff="50">0.54</td><td align="char" valign="top" char="(" charoff="50">17 (36.2)</td><td align="char" valign="top" char="." charoff="50">0.1</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Rural</td><td align="char" valign="top" char="(" charoff="50">213 (72.7)</td><td align="char" valign="top" char="(" charoff="50">391 (74.6)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">30 (63.8)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td colspan="6" align="left" valign="top" charoff="50"><italic>Ethnicity (&#x00025;)</italic></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Turkmen</td><td align="char" valign="top" char="(" charoff="50">166 (56.7)</td><td align="char" valign="top" char="(" charoff="50">282 (53.8)</td><td align="char" valign="top" char="." charoff="50">0.43</td><td align="char" valign="top" char="(" charoff="50">30 (63.8)</td><td align="char" valign="top" char="." charoff="50">0.18</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Non-Turkmen</td><td align="char" valign="top" char="(" charoff="50">127 (43.3)</td><td align="char" valign="top" char="(" charoff="50">242 (46.2)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">17 (36.2)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td colspan="6" align="left" valign="top" charoff="50"><italic>Education (&#x00025;)</italic></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Illiterate</td><td align="char" valign="top" char="(" charoff="50">261 (89.1)</td><td align="char" valign="top" char="(" charoff="50">437 (83.4)</td><td align="char" valign="top" char="." charoff="50">0.02</td><td align="char" valign="top" char="(" charoff="50">37 (87.7)</td><td align="char" valign="top" char="." charoff="50">0.41</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Primary school and higher</td><td align="char" valign="top" char="(" charoff="50">32 (10.9)</td><td align="char" valign="top" char="(" charoff="50">87 (16.6)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">10 (21.3)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td colspan="6" align="left" valign="top" charoff="50"><italic>Alcohol ever use (&#x00025;)</italic></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;No</td><td align="char" valign="top" char="(" charoff="50">287 (98)</td><td align="char" valign="top" char="(" charoff="50">511 (97.5)</td><td align="char" valign="top" char="." charoff="50">0.69</td><td align="char" valign="top" char="(" charoff="50">46 (97.9)</td><td align="char" valign="top" char="." charoff="50">0.88</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Yes</td><td align="char" valign="top" char="(" charoff="50">6 (2)</td><td align="char" valign="top" char="(" charoff="50">13 (2.5)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">1 (2.1)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td colspan="6" align="left" valign="top" charoff="50"><italic>Tobacco and opium use</italic><xref ref-type="fn" rid="t1-fn3">b</xref>
<italic>(&#x00025;)</italic></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Neither</td><td align="char" valign="top" char="(" charoff="50">162 (55.5)</td><td align="char" valign="top" char="(" charoff="50">366 (70.0)</td><td align="char" valign="top" char="." charoff="50">0.0002</td><td align="char" valign="top" char="(" charoff="50">32 (68.1)</td><td align="char" valign="top" char="." charoff="50">0.58</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Ever use tobacco</td><td align="char" valign="top" char="(" charoff="50">43 (14.7)</td><td align="char" valign="top" char="(" charoff="50">59 (11.3)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">7 (14.9)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Ever use opium</td><td align="char" valign="top" char="(" charoff="50">29 (10.0)</td><td align="char" valign="top" char="(" charoff="50">33 (6.3)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">1 (2.1)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Ever use tobacco and opium</td><td align="char" valign="top" char="(" charoff="50">58 (19.8)</td><td align="char" valign="top" char="(" charoff="50">65 (12.4)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">7 (14.9)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td colspan="6" align="left" valign="top" charoff="50"><italic>Fruit and vegetable consumption (&#x00025;)</italic></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02a7d; Median<xref ref-type="fn" rid="t1-fn4">c</xref></td><td align="char" valign="top" char="(" charoff="50">139 (47.4)</td><td align="char" valign="top" char="(" charoff="50">235 (44.8)</td><td align="char" valign="top" char="." charoff="50">0.47</td><td align="char" valign="top" char="(" charoff="50">20 (42.5)</td><td align="char" valign="top" char="." charoff="50">0.76</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x0003e; Median</td><td align="char" valign="top" char="(" charoff="50">154 (52.6)</td><td align="char" valign="top" char="(" charoff="50">289 (55.1)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">27 (57.5)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td colspan="6" align="left" valign="top" charoff="50"><italic>DMFT (&#x00025;)</italic><xref ref-type="fn" rid="t1-fn3">b</xref></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02a7d; Median (28)</td><td align="char" valign="top" char="(" charoff="50">117 (40.3)</td><td align="char" valign="top" char="(" charoff="50">266 (51.0)</td><td align="char" valign="top" char="." charoff="50">0.004</td><td align="char" valign="top" char="(" charoff="50">28 (59.6)</td><td align="char" valign="top" char="." charoff="50">0.25</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x0003e; Median</td><td align="char" valign="top" char="(" charoff="50">173 (59.7)</td><td align="char" valign="top" char="(" charoff="50">256 (49.0)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">19 (40.4)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td colspan="6" align="left" valign="top" charoff="50"><italic>Tooth brushing habit</italic><xref ref-type="fn" rid="t1-fn3">b</xref></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Ever</td><td align="char" valign="top" char="(" charoff="50">59 (20.3)</td><td align="char" valign="top" char="(" charoff="50">221 (42.4)</td><td align="char" valign="top" char="." charoff="50">&#x0003c;0.0001</td><td align="char" valign="top" char="(" charoff="50">18 (39.1)</td><td align="char" valign="top" char="." charoff="50">0.66</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Never</td><td align="char" valign="top" char="(" charoff="50">232 (79.7)</td><td align="char" valign="top" char="(" charoff="50">300 (57.6)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">28 (60.9)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">PGI (<italic>&#x003bc;</italic>g&#x02009;l<sup>&#x02212;1</sup>), median (IQR)</td><td align="char" valign="top" char="(" charoff="50">109.3 (67.2&#x02013;147.5)</td><td align="char" valign="top" char="(" charoff="50">94.9 (66.6&#x02013;123.3)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">NA</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">PGII (<italic>&#x003bc;</italic>g&#x02009;l<sup>&#x02212;1</sup>), median (IQR)</td><td align="char" valign="top" char="(" charoff="50">14.2 (9.6&#x02013;21.5)</td><td align="char" valign="top" char="(" charoff="50">12.3 (8.8&#x02013;18.2)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">NA</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">PGI/PGII ratio, median (IQR)</td><td align="char" valign="top" char="(" charoff="50">7.0 (4.8&#x02013;9.7)</td><td align="char" valign="top" char="(" charoff="50">7.2 (5.3&#x02013;9.9)</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">NA</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="t1-fn1"><p>Abbreviations: DMFT=Sum of decayed, missed, and filled teeth; IQR=interquartile range; NA=not applicable; OSCC=oesophageal squamous cell carcinoma.</p></fn><fn id="t1-fn2"><label>a</label><p><italic>P</italic>-value for significance of difference between controls with and without serum samples.</p></fn><fn id="t1-fn3"><label>b</label><p>Numbers of cases and controls were less than total because of missed data.</p></fn><fn id="t1-fn4"><label>c</label><p>Median fruit and vegetable consumption=521.8 gr/day.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2"><label>Table 2</label><caption><title>Levels of pepsinogen I, pepsinogen II, and <italic>H. pylori</italic> serology and their associations with OSCC risk, Golestan province, Iran, 2003&#x02013;2007</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="char" char="("/><col align="char" char="("/><col align="char" char="("/><col align="char" char="("/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" char="(" charoff="50"><bold>Controls,</bold>
<italic><bold>N</bold></italic>
<bold>(&#x00025;)</bold></th><th align="center" valign="top" char="(" charoff="50"><bold>Cases,</bold>
<italic><bold>N</bold></italic>
<bold>(&#x00025;)</bold></th><th align="center" valign="top" char="(" charoff="50"><bold>Crude OR (95&#x00025; CI)</bold></th><th align="center" valign="top" char="(" charoff="50"><bold>Adjusted OR (95&#x00025; CI)</bold><xref ref-type="fn" rid="t2-fn2">a</xref></th></tr></thead><tbody valign="top"><tr><td colspan="5" align="left" valign="top" charoff="50"><italic>PGI (&#x003bc;g&#x02009;l</italic><sup><italic>&#x02212;1</italic></sup>)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02a7e; 55</td><td align="char" valign="top" char="(" charoff="50">449 (85.7)</td><td align="char" valign="top" char="(" charoff="50">238 (81.2)</td><td align="center" valign="top" char="(" charoff="50">Referent</td><td align="center" valign="top" char="(" charoff="50">Referent</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x0003c; 55</td><td align="char" valign="top" char="(" charoff="50">75 (14.3)</td><td align="char" valign="top" char="(" charoff="50">55 (18.8)</td><td align="char" valign="top" char="(" charoff="50">1.33 (0.89&#x02013;1.97)</td><td align="char" valign="top" char="(" charoff="50">1.39 (0.93&#x02013;2.09)</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td></tr><tr><td colspan="5" align="left" valign="top" charoff="50"><italic>PGII</italic><xref ref-type="fn" rid="t2-fn3">b</xref>
<italic>(&#x003bc;g&#x02009;l</italic><sup><italic>&#x02212;1</italic></sup>)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x0003c;11.8</td><td align="char" valign="top" char="(" charoff="50">246 (46.9)</td><td align="char" valign="top" char="(" charoff="50">113 (38.7)</td><td align="center" valign="top" char="(" charoff="50">Referent</td><td align="center" valign="top" char="(" charoff="50">Referent</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;&#x02a7e; 11.8</td><td align="char" valign="top" char="(" charoff="50">278 (53.1)</td><td align="char" valign="top" char="(" charoff="50">179 (63.1)</td><td align="char" valign="top" char="(" charoff="50">1.37 (1.01&#x02013;1.85)</td><td align="char" valign="top" char="(" charoff="50">1.40 (1.01&#x02013;1.92)</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td></tr><tr><td colspan="5" align="left" valign="top" charoff="50"><italic>PGI and PGII</italic><xref ref-type="fn" rid="t2-fn3">b</xref>
<italic>(&#x003bc;g&#x02009;l</italic><sup><italic>&#x02212;1</italic></sup>)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;PGI &#x02a7e;55 and PGII&#x0003c;11.8</td><td align="char" valign="top" char="(" charoff="50">189 (36.1)</td><td align="char" valign="top" char="(" charoff="50">71 (24.2)</td><td align="center" valign="top" char="(" charoff="50">Referent</td><td align="center" valign="top" char="(" charoff="50">Referent</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;PGI &#x0003c;55 and PGII &#x0003c;11.8</td><td align="char" valign="top" char="(" charoff="50">57 (10.9)</td><td align="char" valign="top" char="(" charoff="50">42 (14.3)</td><td align="char" valign="top" char="(" charoff="50">1.92 (1.15&#x02013;3.22)</td><td align="char" valign="top" char="(" charoff="50">2.01 (1.18&#x02013;3.45)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;PGI &#x02a7e;55 and PGII &#x02a7e;11.8</td><td align="char" valign="top" char="(" charoff="50">260 (49.6)</td><td align="char" valign="top" char="(" charoff="50">167 (57)</td><td align="center" valign="top" char="(" charoff="50">Referent</td><td align="center" valign="top" char="(" charoff="50">Referent</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;PGI&#x0003c;55 and PGII &#x02a7e;11.8</td><td align="char" valign="top" char="(" charoff="50">18 (3.4)</td><td align="char" valign="top" char="(" charoff="50">12 (4.4)</td><td align="char" valign="top" char="(" charoff="50">1.02 (0.47&#x02013;2.23)</td><td align="char" valign="top" char="(" charoff="50">1.20 (0.54&#x02013;2.66)</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td></tr><tr><td colspan="5" align="left" valign="top" charoff="50"><italic>H. pylori status</italic></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;<italic>H. pylori</italic>&#x02212; cagA&#x02212;</td><td align="char" valign="top" char="(" charoff="50">52 (10)</td><td align="char" valign="top" char="(" charoff="50">35 (12)</td><td align="center" valign="top" char="(" charoff="50">Referent</td><td align="center" valign="top" char="(" charoff="50">Referent</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;<italic>H. pylori</italic>&#x0002b; cagA&#x02212;</td><td align="char" valign="top" char="(" charoff="50">34 (6.5)</td><td align="char" valign="top" char="(" charoff="50">14 (4.8)</td><td align="char" valign="top" char="(" charoff="50">0.64 (0.30&#x02013;1.35)</td><td align="char" valign="top" char="(" charoff="50">0.70 (0.32&#x02013;1.53)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;<italic>H. pylori</italic>&#x0002b; cagA&#x0002b;</td><td align="char" valign="top" char="(" charoff="50">351 (67.2)</td><td align="char" valign="top" char="(" charoff="50">179 (61.3)</td><td align="char" valign="top" char="(" charoff="50">0.73 (0.46&#x02013;1.17)</td><td align="char" valign="top" char="(" charoff="50">0.79 (0.48&#x02013;1.29)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;<italic>H. pylori</italic>&#x02212; cagA&#x0002b;</td><td align="char" valign="top" char="(" charoff="50">85 (16.3)</td><td align="char" valign="top" char="(" charoff="50">64 (21.9)</td><td align="char" valign="top" char="(" charoff="50">1.05 (0.60&#x02013;1.85)</td><td align="char" valign="top" char="(" charoff="50">1.15 (0.63&#x02013;2.08)</td></tr></tbody></table><table-wrap-foot><fn id="t2-fn1"><p>Abbreviations: cagA=cytotoxin-associated gene A; CI=confidence interval; <italic>H. pylori=Helicobacter pylori</italic>; OR=odds ratio; OSCC=oesophageal squamous cell carcinoma; PGI=pepsinogen I; PGII=pepsinogen II.</p></fn><fn id="t2-fn2"><label>a</label><p>Adjusted for ethnicity (Non-Turkmen or Turkmen), alcohol consumption (never or ever), tobacco or opium use (none, only tobacco, only opium, or both), education level (illiterate, primary school or more), and vegetable/fruit consumption.</p></fn><fn id="t2-fn3"><label>b</label><p>For one case, PGII level was missing and just PGI level was available.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl3"><label>Table 3</label><caption><title>Gastric atrophy defined by other serology criteria in literature and its association with OSCC risk</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="char" char="("/><col align="char" char="("/><col align="char" char="("/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" char="(" charoff="50"><bold>Controls,</bold>
<italic><bold>N</bold></italic>
<bold>(&#x00025;)</bold></th><th align="center" valign="top" char="(" charoff="50"><bold>Cases,</bold>
<italic><bold>N</bold></italic>
<bold>(&#x00025;)</bold></th><th align="center" valign="top" char="(" charoff="50"><bold>Adjusted OR (95&#x00025; CI)</bold><xref ref-type="fn" rid="t3-fn2">a</xref></th></tr></thead><tbody valign="top"><tr><td colspan="4" align="left" valign="top" charoff="50"><italic>PGI</italic></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;PGI &#x02a7e;30</td><td align="char" valign="top" char="(" charoff="50">500 (95.4)</td><td align="char" valign="top" char="(" charoff="50">274 (93.5)</td><td align="center" valign="top" char="(" charoff="50">Referent</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;PGI &#x0003c;30</td><td align="char" valign="top" char="(" charoff="50">24 (4.6)</td><td align="char" valign="top" char="(" charoff="50">19 (6.5)</td><td align="char" valign="top" char="(" charoff="50">1.52 (0.79&#x02013;2.93)</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td></tr><tr><td colspan="4" align="left" valign="top" charoff="50"><italic>Stratifying by PGII level</italic><xref ref-type="fn" rid="t3-fn3">b</xref></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;PGI &#x02a7e;30 and PGII&#x0003c;11.8</td><td align="char" valign="top" char="(" charoff="50">226 (43.1)</td><td align="char" valign="top" char="(" charoff="50">97 (33.1)</td><td align="center" valign="top" char="(" charoff="50">Referent</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;PGI &#x0003c;30 and PGII &#x0003c;11.8</td><td align="char" valign="top" char="(" charoff="50">4 (0.8)</td><td align="char" valign="top" char="(" charoff="50">3 (1.0)</td><td align="char" valign="top" char="(" charoff="50">1.94 (0.91&#x02013;4.13)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;PGI &#x02a7e;30 and PGII &#x02a7e;11.8</td><td align="char" valign="top" char="(" charoff="50">274 (52.3)</td><td align="char" valign="top" char="(" charoff="50">176 (60.4)</td><td align="center" valign="top" char="(" charoff="50">Referent</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;PGI &#x0003c;30 and PGII &#x02a7e;11.8</td><td align="char" valign="top" char="(" charoff="50">20 (3.8)</td><td align="char" valign="top" char="(" charoff="50">16 (5.5)</td><td align="char" valign="top" char="(" charoff="50">1.10 (0.23&#x02013;5.17)</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td></tr><tr><td colspan="4" align="left" valign="top" charoff="50"><italic>PGI/PGII ratio</italic><xref ref-type="fn" rid="t3-fn3">b</xref></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Ratio &#x02a7e;3</td><td align="char" valign="top" char="(" charoff="50">490 (93.5)</td><td align="char" valign="top" char="(" charoff="50">265 (90.8)</td><td align="center" valign="top" char="(" charoff="50">Referent</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Ratio &#x0003c;3</td><td align="char" valign="top" char="(" charoff="50">34 (6.5)</td><td align="char" valign="top" char="(" charoff="50">27 (9.2)</td><td align="char" valign="top" char="(" charoff="50">1.50 (0.85&#x02013;2.60)</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td><td align="char" valign="top" char="(" charoff="50">&#x000a0;</td></tr><tr><td colspan="4" align="left" valign="top" charoff="50"><italic>Stratifying by PGII level</italic><xref ref-type="fn" rid="t3-fn3">b</xref></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Ratio &#x02a7e;3 and PGII &#x0003c;11.8</td><td align="char" valign="top" char="(" charoff="50">233 (44.5)</td><td align="char" valign="top" char="(" charoff="50">100 (34.1)</td><td align="center" valign="top" char="(" charoff="50">Referent</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Ratio &#x0003c;3 and PGII &#x0003c;11.8</td><td align="char" valign="top" char="(" charoff="50">21 (4.0)</td><td align="char" valign="top" char="(" charoff="50">14 (4.8)</td><td align="char" valign="top" char="(" charoff="50">2.32 (1.00&#x02013;5.39)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Ratio &#x02a7e;3 and PGII &#x02a7e;11.8</td><td align="char" valign="top" char="(" charoff="50">257 (49.0)</td><td align="char" valign="top" char="(" charoff="50">165 (56.7)</td><td align="center" valign="top" char="(" charoff="50">Referent</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;Ratio&#x0003c;30 and PGII &#x02a7e;11.8</td><td align="char" valign="top" char="(" charoff="50">13 (2.5)</td><td align="char" valign="top" char="(" charoff="50">13 (4.4)</td><td align="char" valign="top" char="(" charoff="50">1.03 (0.49&#x02013;2.20)</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td></tr><tr><td colspan="4" align="left" valign="top" charoff="50"><italic>PGI and PGI/PGII ratio</italic><xref ref-type="fn" rid="t3-fn3">b</xref></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;PGI &#x02a7e;70 or ratio &#x02a7e;3</td><td align="char" valign="top" char="(" charoff="50">497 (94.9)</td><td align="char" valign="top" char="(" charoff="50">267 (91.5)</td><td align="center" valign="top" char="(" charoff="50">Referent</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;PGI &#x0003c;70 and ratio &#x0003c;3</td><td align="char" valign="top" char="(" charoff="50">27 (5.1)</td><td align="char" valign="top" char="(" charoff="50">25 (8.5)</td><td align="char" valign="top" char="(" charoff="50">1.69 (0.93&#x02013;3.10)</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50">&#x000a0;</td></tr><tr><td colspan="4" align="left" valign="top" charoff="50"><italic>Stratifying by PGII level</italic><xref ref-type="fn" rid="t3-fn3">b</xref></td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;(PGI &#x02a7e;70 or ratio &#x02a7e;3) and PGII &#x0003c;11.8</td><td align="char" valign="top" char="(" charoff="50">233 (44.5)</td><td align="char" valign="top" char="(" charoff="50">100 (34.19)</td><td align="center" valign="top" char="(" charoff="50">Referent</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;(PGI &#x0003c;70 and ratio &#x0003c;3) and PGII &#x0003c;11.8</td><td align="char" valign="top" char="(" charoff="50">14 (2.6)</td><td align="char" valign="top" char="(" charoff="50">12 (4.1)</td><td align="char" valign="top" char="(" charoff="50">2.31 (0.99&#x02013;5.38)</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;(PGI &#x02a7e;70 or ratio &#x02a7e;3) and PGII &#x02a7e;11.8</td><td align="char" valign="top" char="(" charoff="50">264 (50.4)</td><td align="char" valign="top" char="(" charoff="50">167 (57.4)</td><td align="center" valign="top" char="(" charoff="50">Referent</td></tr><tr><td align="left" valign="top" charoff="50">&#x02003;(PGI &#x0003c;70 and ratio &#x0003c;3) and PGII &#x02a7e;11.8</td><td align="char" valign="top" char="(" charoff="50">13 (2.5)</td><td align="char" valign="top" char="(" charoff="50">13 (4.4)</td><td align="char" valign="top" char="(" charoff="50">1.24 (0.52&#x02013;2.94)</td></tr></tbody></table><table-wrap-foot><fn id="t3-fn1"><p>Abbreviations: CI=confidence interval; OR=odds ratio; OSCC=oesophageal squamous cell carcinoma; PGI=pepsinogen I; PGII=pepsinogen II.</p></fn><fn id="t3-fn2"><label>a</label><p>Adjusted for ethnicity (Non-Turkmen or Turkmen), alcohol consumption (never or ever), tobacco or opium use (none, only tobacco, only opium, or both), education level (illiterate, primary school or more), and vegetable/fruit consumption.</p></fn><fn id="t3-fn3"><label>b</label><p>For one case, PGII level was missing and just PGI level was available.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl4"><label>Table 4</label><caption><title>Combined effects of gastric atrophy and dental health or oral hygiene habit on OSCC risk after breaking the matching factors</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="char" char="("/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th colspan="2" align="center" valign="top" charoff="50"><bold>Gastric atrophy &#x02212;</bold><hr/></th><th colspan="2" align="center" valign="top" charoff="50"><bold>Gastric atrophy &#x0002b;</bold><hr/></th></tr><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50"><bold>Case/control</bold></th><th align="center" valign="top" charoff="50"><bold>OR</bold><xref ref-type="fn" rid="t4-fn4">a</xref>
<bold>(95&#x00025; CI)</bold></th><th align="center" valign="top" charoff="50"><bold>Case/control</bold></th><th align="center" valign="top" char="(" charoff="50"><bold>OR</bold><xref ref-type="fn" rid="t4-fn4">a</xref>
<bold>(95&#x00025; CI)</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">DMFT &#x02a7d;28</td><td align="center" valign="top" charoff="50">29/104</td><td align="center" valign="top" charoff="50">Referent</td><td align="center" valign="top" charoff="50">12/26</td><td align="char" valign="top" char="(" charoff="50">1.65 (0.74&#x02013;3.67)</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50"><italic>P</italic>=0.20</td></tr><tr><td align="left" valign="top" charoff="50">DMFT &#x0003e;28</td><td align="center" valign="top" charoff="50">40/84</td><td align="char" valign="top" char="(" charoff="50">1.71 (0.98&#x02013;2.98)</td><td align="center" valign="top" charoff="50">30/31</td><td align="char" valign="top" char="(" charoff="50">3.47 (1.81&#x02013;6.64)</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50"><italic>P</italic>=0.06</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50"><italic>P</italic> &#x0003c;0.001</td></tr><tr><td align="left" valign="top" charoff="50">Ever tooth brushing</td><td align="center" valign="top" charoff="50">14/87</td><td align="center" valign="top" charoff="50">Referent</td><td align="center" valign="top" charoff="50">5/24</td><td align="char" valign="top" char="(" charoff="50">1.40 (0.44&#x02013;4.39)</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50"><italic>P</italic>=0.57</td></tr><tr><td align="left" valign="top" charoff="50">Never tooth brushing</td><td align="center" valign="top" charoff="50">57/100</td><td align="char" valign="top" char="(" charoff="50">4.12 (2.05&#x02013;8.28)</td><td align="center" valign="top" charoff="50">37/33</td><td align="char" valign="top" char="(" charoff="50">8.77 (3.89&#x02013;19.72)</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50"><italic>P</italic> &#x0003c;0.001</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="(" charoff="50"><italic>P</italic> &#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="t4-fn1"><p>Abbreviations: CI=confidence interval; DMFT=sum of decayed, missed, and filled teeth; OR=odds ratio; OSCC=oesophageal squamous cell carcinoma.</p></fn><fn id="t4-fn2"><p>Measure of interaction on additive scale: relative excess risk due to interaction with low DMFT (95&#x00025; CI): 1.47 (&#x02212;1.15 to 4.1) and with never tooth brushing habit (95&#x00025; CI): 4.34 (&#x02212;1.07 to 9.76).</p></fn><fn id="t4-fn3"><p>Measure of interaction on multiplicative scale: between atrophy and low DMFT: OR (95&#x00025; CI): 1.44 (0.63&#x02013;3.32); <italic>P</italic>=0.39 and measure of interaction between atrophy and never tooth brushing on multiplicative scale: OR (95&#x00025; CI): 1.78 (0.30&#x02013;10.42); <italic>P</italic>=0.52.</p></fn><fn id="t4-fn4"><label>a</label><p>ORs (95&#x00025; CI) levels adjusted for age, sex, residence area, ethnicity (Non-Turkmen or Turkmen), alcohol consumption (never or ever), tobacco or opium use (none, only tobacco, only opium, or both), education level (illiterate, primary school or more), and vegetable/fruit consumption.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl5"><label>Table 5</label><caption><title>Gastric atrophy defined by PGI &#x0003c;55&#x02009;<italic>&#x003bc;</italic>g&#x02009;l<sup>&#x02212;1</sup> and its association with OSCC risk under assumption of various sensitivity (se) and specificity (sp) among cases and controls</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50"><bold>Controls All PGII</bold></th><th align="center" valign="top" charoff="50"><bold>Only PGII &#x0003c;5</bold></th><th align="center" valign="top" charoff="50"><bold>Only PGII &#x0003c;11.8</bold></th><th align="center" valign="top" charoff="50"><bold>Only PGII &#x0003c;15</bold></th><th align="center" valign="top" charoff="50"><bold>Only PGII &#x0003c;19</bold></th><th align="center" valign="top" charoff="50"><bold>Only PGII &#x0003c;30</bold></th><th align="center" valign="top" charoff="50"><bold>Only PGII &#x0003e;11.8</bold></th></tr><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50"><bold>Se: 0.62</bold></th><th align="center" valign="top" charoff="50"><bold>0.99</bold></th><th align="center" valign="top" charoff="50"><bold>0.83</bold></th><th align="center" valign="top" charoff="50"><bold>0.80</bold></th><th align="center" valign="top" charoff="50"><bold>0.80</bold></th><th align="center" valign="top" charoff="50"><bold>0.76</bold></th><th align="center" valign="top" charoff="50"><bold>0.37</bold></th></tr><tr><th align="left" valign="top" charoff="50">&#x000a0;<hr/></th><th align="center" valign="top" charoff="50">&#x000a0;<hr/></th><th align="center" valign="top" charoff="50">&#x000a0;<hr/></th><th align="center" valign="top" charoff="50"><bold>Sp: 0.95</bold><hr/></th><th align="center" valign="top" charoff="50"><bold>0.68</bold><hr/></th><th align="center" valign="top" charoff="50"><bold>0.89</bold><hr/></th><th align="center" valign="top" charoff="50"><bold>0.91</bold><hr/></th><th align="center" valign="top" charoff="50"><bold>0.92</bold><hr/></th><th align="center" valign="top" charoff="50"><bold>0.94</bold><hr/></th><th align="center" valign="top" charoff="50"><bold>0.98</bold><hr/></th></tr><tr><th align="left" valign="top" charoff="50"><bold>Cases</bold></th><th align="center" valign="top" charoff="50"><bold>Se</bold></th><th align="center" valign="top" charoff="50"><bold>Sp</bold></th><th align="center" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">&#x000a0;</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">All PGII</td><td align="char" valign="top" char="." charoff="50">0.62</td><td align="char" valign="top" char="." charoff="50">0.95</td><td align="char" valign="top" char="." charoff="50">1.63</td><td align="center" valign="top" charoff="50"><xref ref-type="fn" rid="t5-fn3">a</xref></td><td align="char" valign="top" char="." charoff="50">6.6</td><td align="char" valign="top" char="." charoff="50">3.9</td><td align="char" valign="top" char="." charoff="50">3.3</td><td align="char" valign="top" char="." charoff="50">2.4</td><td align="char" valign="top" char="." charoff="50">0.59</td></tr><tr><td align="left" valign="top" charoff="50">Only PGII &#x0003c;5</td><td align="char" valign="top" char="." charoff="50">0.99</td><td align="char" valign="top" char="." charoff="50">0.68</td><td align="center" valign="top" charoff="50"><xref ref-type="fn" rid="t5-fn3">a</xref></td><td align="char" valign="top" char="." charoff="50">0.79</td><td align="center" valign="top" charoff="50"><xref ref-type="fn" rid="t5-fn3">a</xref></td><td align="center" valign="top" charoff="50"><xref ref-type="fn" rid="t5-fn3">a</xref></td><td align="center" valign="top" charoff="50"><xref ref-type="fn" rid="t5-fn3">a</xref></td><td align="center" valign="top" charoff="50"><xref ref-type="fn" rid="t5-fn3">a</xref></td><td align="center" valign="top" charoff="50"><xref ref-type="fn" rid="t5-fn3">a</xref></td></tr><tr><td align="left" valign="top" charoff="50">Only PGII &#x0003c;11.8</td><td align="char" valign="top" char="." charoff="50">0.83</td><td align="char" valign="top" char="." charoff="50">0.89</td><td align="char" valign="top" char="." charoff="50">0.6</td><td align="center" valign="top" charoff="50">a<xref ref-type="fn" rid="t5-fn1"/></td><td align="char" valign="top" char="." charoff="50">2.5</td><td align="char" valign="top" char="." charoff="50">1.5</td><td align="char" valign="top" char="." charoff="50">1.3</td><td align="char" valign="top" char="." charoff="50">0.9</td><td align="char" valign="top" char="." charoff="50">0.2</td></tr><tr><td align="left" valign="top" charoff="50">Only PGII &#x0003c;15</td><td align="char" valign="top" char="." charoff="50">0.80</td><td align="char" valign="top" char="." charoff="50">0.91</td><td align="char" valign="top" char="." charoff="50">0.8</td><td align="center" valign="top" charoff="50">a<xref ref-type="fn" rid="t5-fn1"/></td><td align="char" valign="top" char="." charoff="50">3.3</td><td align="char" valign="top" char="." charoff="50">1.97</td><td align="char" valign="top" char="." charoff="50">1.7</td><td align="char" valign="top" char="." charoff="50">1.2</td><td align="char" valign="top" char="." charoff="50">0.3</td></tr><tr><td align="left" valign="top" charoff="50">Only PGII &#x0003c;19</td><td align="char" valign="top" char="." charoff="50">0.80</td><td align="char" valign="top" char="." charoff="50">0.92</td><td align="char" valign="top" char="." charoff="50">0.9</td><td align="center" valign="top" charoff="50"><xref ref-type="fn" rid="t5-fn3">a</xref></td><td align="char" valign="top" char="." charoff="50">3.6</td><td align="char" valign="top" char="." charoff="50">2.2</td><td align="char" valign="top" char="." charoff="50">1.83</td><td align="char" valign="top" char="." charoff="50">1.3</td><td align="char" valign="top" char="." charoff="50">0.3</td></tr><tr><td align="left" valign="top" charoff="50">Only PGII &#x0003c;30</td><td align="char" valign="top" char="." charoff="50">0.76</td><td align="char" valign="top" char="." charoff="50">0.94</td><td align="char" valign="top" char="." charoff="50">1.1</td><td align="center" valign="top" charoff="50"><xref ref-type="fn" rid="t5-fn3">a</xref></td><td align="char" valign="top" char="." charoff="50">4.6</td><td align="char" valign="top" char="." charoff="50">2.8</td><td align="char" valign="top" char="." charoff="50">2.3</td><td align="char" valign="top" char="." charoff="50">1.65</td><td align="char" valign="top" char="." charoff="50">1.66</td></tr><tr><td align="left" valign="top" charoff="50">Only PGII &#x0003e;11.8</td><td align="char" valign="top" char="." charoff="50">0.37</td><td align="char" valign="top" char="." charoff="50">0.98</td><td align="char" valign="top" char="." charoff="50">4.7</td><td align="center" valign="top" charoff="50"><xref ref-type="fn" rid="t5-fn3">a</xref></td><td align="char" valign="top" char="." charoff="50">19.1</td><td align="char" valign="top" char="." charoff="50">11.4</td><td align="char" valign="top" char="." charoff="50">9.6</td><td align="char" valign="top" char="." charoff="50">6.8</td><td align="char" valign="top" char="." charoff="50">1.69</td></tr></tbody></table><table-wrap-foot><fn id="t5-fn1"><p>Abbreviations: OSCC=oesophageal squamous cell carcinoma; PGI=pepsinogen I; PGII=pepsinogen II.</p></fn><fn id="t5-fn2"><p>ORs are adjusted for age, sex, and residence area in unconditional logistic regression model.</p></fn><fn id="t5-fn3"><label>a</label><p>These cells yielded negative adjusted counts, which were impossible values for true counts, thus corrected ORs could not be estimated.</p></fn></table-wrap-foot></table-wrap></floats-group></article>